China: Robot doctors at world’s 1st AI hospital can treat 3,000 a day

The world is making significant inroads into utilizing artificial intelligence (AI) technology to advance functions in various domains, especially healthcare.

We have seen AI technologies helping to advance personalized medicine, predictive analytics, drug discovery and development, smart virtual health assistants, and furthering medical imaging and diagnostics.

Now, a Chinese state media outlet reports that the country has developed its first AI hospital town, a concept in which virtual patients are attended to by AI doctors.

The system, developed by a team at Tsinghua University in Beijing, aims to advance medical consultation by training doctor agents in a simulated environment. The team says this will equip them to evolve independently and enhance their ability to treat diseases.

According to Global Times, researchers claim the model will help further AI doctors’ diagnostic capabilities from the virtual realm to real-world applications and the potential for high-quality, affordable, and convenient healthcare services for the public.

Virtual patient simulation

The Agent Hospital concept enables real doctors to treat virtual patients, offering medical students advanced training opportunities. By simulating a diverse array of AI patients, medical students can confidently devise treatment plans without the risk of harming real patients due to decision-making errors.

In this virtual world, all doctors, nurses, and patients are driven by large language model (LLM)–powered intelligent agents capable of autonomous interaction.

According to Global Times, evolved AI doctor agents in the Agent Hospital have achieved an impressive 93.06 percent accuracy rate on a MedQA dataset (US Medical Licensing Exam questions) covering major respiratory diseases.

These intelligent agents can simulate the entire process of diagnosing and treating patients, from consultation and examination to diagnosis, treatment, and follow-up.

According to the team, AI doctors can treat 10,000 patients in just a few days—a task that would take humans at least two years to complete.

The university team points out that AI hospital town can simulate and forecast various medical situations, including the emergence, spread, and containment of infectious diseases within an area.

Keep reading

Antidepressants During Pregnancy Raise Risk of Birth Defects, Doctors Tell FDA

The U.S. Food and Drug Administration (FDA) needs to do a better job of warning pregnant women that taking SSRIs, a type of antidepressant, may harm them and their developing baby, doctors told the agency Monday.

The FDA hosted an expert panel of developmental biologists, psychiatrists, epidemiologists, obstetricians and mental health experts who discussed selective serotonin reuptake inhibitors (SSRIs) and pregnancy. The agency livestreamed the two-hour conversation on YouTube and X.

SSRIs have been “implicated in different studies to be involved in postpartum hemorrhage, pulmonary hypertension and cognitive downstream effects in the baby, as well as cardiac birth defects,” said FDA Commissioner Marty Makary, who opened the event.

Nearly 1 in 4 middle-aged women and up to 5% of pregnant women are on an antidepressant, Makary said.

“Antidepressants like SSRIs can be an effective treatment for depression, but we have to stop and also look at the big picture,” he said. “The more antidepressants we prescribe, the more depression there is. … We have to start talking about root causes.”

SSRIs in particular warrant scrutiny as serotonin “may play a crucial role in the development of organs of a baby in utero,” he said.

Keep reading

The Wearables Trap: How the Government Plans to Monitor, Score, and Control You

Bodily autonomy—the right to privacy and integrity over our own bodies—is rapidly vanishing. The debate now extends beyond forced vaccinations or invasive searches to include biometric surveillance, wearable tracking, and predictive health profiling.

We are entering a new age of algorithmic, authoritarian control, where our thoughts, moods, and biology are monitored and judged by the state.

This is the dark promise behind the newest campaign by Robert F. Kennedy Jr., President Trump’s Secretary of Health and Human Services, to push for a future in which all Americans wear biometric health-tracking devices.

Under the guise of public health and personal empowerment, this initiative is nothing less than the normalization of 24/7 bodily surveillance—ushering in a world where every step, heartbeat, and biological fluctuation is monitored not only by private companies but also by the government.

In this emerging surveillance-industrial complex, health data becomes currency. Tech firms profit from hardware and app subscriptions, insurers profit from risk scoring, and government agencies profit from increased compliance and behavioral insight.

This convergence of health, technology, and surveillance is not a new strategy—it’s just the next step in a long, familiar pattern of control.

Surveillance has always arrived dressed as progress.

Every new wave of surveillance technology—GPS trackers, red light cameras, facial recognition, Ring doorbells, Alexa smart speakers—has been sold to us as a tool of convenience, safety, or connection. But in time, each became a mechanism for tracking, monitoring, or controlling the public.

What began as voluntary has become inescapable and mandatory.

Keep reading

Organ donors’ lives endangered by rushed transplant procedures, investigation finds

As a new report claims that premature organ transplants have endangered donors, HHS Sec. Robert F. Kennedy Jr. has announced plans for a new initiative to reform the system.

Several families have stated that surgeons attempted to initiate organ retrievals while patients were still alive or improving, as noted in a July 20 report from The New York Times.

Amid a growing push for increased transplants, “a growing number of patients have endured premature or bungled attempts to retrieve their organs,” according to the report, which painted a picture of “rushed decision-making” and organ demand taking priority over donor safety.

In a recent investigation by the Health Resources and Services Administration (HRSA), there were more than 70 canceled organ removals in Kentucky alone “that should have been stopped sooner” because the patients showed signs of revival, the report stated.

The problem appears to be linked to an increase in “donation after circulatory death,” which is when the patient has not been declared “brain dead” but is critically ill or injured.

Keep reading

How Big Pharma Hijacked Evidence-Based Medicine

I. Introduction

Evidence-Based Medicine (EBM) is a relatively recent phenomenon. The term itself was not coined until 1991. It began with the best of intentions — to give frontline doctors the tools from clinical epidemiology to make science-based decisions that would improve patient outcomes. But over the last three decades, EBM has been hijacked by the pharmaceutical industry to serve the interests of shareholders rather than patients.

Today, EBM gives preference to epistemologies that favor corporate interests while instructing doctors to ignore other valid forms of knowledge and their own professional experience. This shift disempowers doctors and reduces patients to objects while concentrating power in the hands of pharmaceutical companies. EBM also leaves doctors ill-equipped to respond to the autism epidemic and unable to produce the sorts of paradigm-shifts that would be necessary to address this crisis.

In this article I will:

  • provide a brief history of EBM;
  • explain how evidence hierarchies work;
  • explore ten general and technical criticisms of EBM and evidence hierarchies;
  • examine the American Medical Association’s 2002, 2008, and 2015 evidence hierarchies;
  • highlight the corporate takeover of EBM; and
  • explore the implications of these dynamics for the autism epidemic.

Keep reading

Midazolam murder: “If you want to kill somebody, get a doctor or a nurse to do it”

Derek Dimmock, an 86-year-old man from Putney, UK, was admitted to the Royal Trinity Hospice in June 2020 with gout and later died under controversial circumstances.  His family is alleging he was involuntarily euthanised using midazolam, a sedative often used in end-of-life care.

His family claims he was given a cocktail of end-of-life drugs, including midazolam, which they argue was inappropriate and hastened his death.  Derek was given enough midazolam to “kill an elephant,” a source close to the family said.

The case is currently under investigation, with an inquest examining whether his death was a natural occurrence or an unlawful killing.  The case was heard by a Senior Coroner in March; the inquest resumes in August 2025.

During an interview, the barrister for the Dimmock family explained how midazolam is used by the NHS to end someone’s life and said, “If you want to kill somebody, get a doctor or a nurse to do it, because it’s very, very difficult to pin the blame on them.”

Barrister James Bogle, who specialises in clinical negligence, is representing the Dimmock family in a legal capacity.  Bogle is familiar with the state’s abuse and misuse of drugs to end people’s lives.  In 2023 he provided the legal analysis for the report titled ‘When end of life care goes wrong’, which examined the excessive and inappropriate use of midazolam and morphine in the UK.  The report is available from Voice for Justice UK, see HERE.

At the end of June, Bogle joined Peter McCormack’s podcast, during which he said “the favoured way of shortening a life” is the use of a combination of midazolam and morphine.  In the following, Maajid Nawaz explains more.

Keep reading

The Wearables Trap: How The Government Plans To Monitor, Score, And Control You

When the states legalize the deliberate ending of certain lives… it will eventually broaden the categories of those who can be put to death with impunity.”—Nat Hentoff, The Washington Post, 1992

Bodily autonomy—the right to privacy and integrity over our own bodies—is rapidly vanishing.

The debate now extends beyond forced vaccinations or invasive searches to include biometric surveillance, wearable tracking, and predictive health profiling.

We are entering a new age of algorithmic, authoritarian control, where our thoughts, moods, and biology are monitored and judged by the state.

This is the dark promise behind the newest campaign by Robert F. Kennedy Jr., President Trump’s Secretary of Health and Human Services, to push for a future in which all Americans wear biometric health-tracking devices.

Under the guise of public health and personal empowerment, this initiative is nothing less than the normalization of 24/7 bodily surveillance—ushering in a world where every step, heartbeat, and biological fluctuation is monitored not only by private companies but also by the government.

In this emerging surveillance-industrial complex, health data becomes currency. Tech firms profit from hardware and app subscriptions, insurers profit from risk scoring, and government agencies profit from increased compliance and behavioral insight.

This convergence of health, technology, and surveillance is not a new strategy—it’s just the next step in a long, familiar pattern of control.

Surveillance has always arrived dressed as progress.

Keep reading

Update on International Health Regulation Amendments

Much has been written on the amendments to the International Health Regulations (IHR), which most countries are making themselves subject to after July 19th (next week). Many raise concerns of loss of sovereignty, censorship, corporate greed, and conflict of interest. But most are missing the main point; the sheer and outright stupidity and fallacy on which the whole pandemic agenda is based.

July 19th is the last day that Member States of the World Health Organization (WHO) can withdraw from the IHR amendments (without entering a multi-year withdrawal process). By failing to withdraw, they will be committing their taxpayers to fund the key surveillance aspects of a rapidly expanding industry that is the pandemic industrial complex. They will be required to set up an extensive network to search for well-established natural phenomena, including the tendency of viruses to mutate into variants. This has been part of the natural world for hundreds of millions of years, but demonstrating it has recently become highly profitable due to a confluence of technological advances and intense marketing.

Firstly, we have developed the ability to detect variants with technologies such as PCR and gene sequencing. This also helps find a lot of viruses that we had not noticed before as they are mostly harmless. Secondly, we have developed digital identification and communications technologies that allow an unprecedented level of mass media coordination and public coercion – what Goebbels could do on a national scale, we can now do almost globally. Thirdly, we have developed pay-to-print modified-RNA medicines (vaccines) that are really cheap but, through the use of fear and coercion, can be injected into almost everyone, returning excellent profits.

Keep reading

Trump DOJ Delivers Bad News to More Than 20 Doctors Who Performed Trans Procedures on Minors

Will the doctors who destroyed children’s bodies and ruined their lives be held accountable?

A news release from the Department of Justice looks promising. On Wednesday, the DOJ stated it would subpoena doctors and clinics that performed transgender surgeries on minors.

“Today, the Department of Justice announced that it has sent more than 20 subpoenas to doctors and clinics involved in performing transgender medical procedures on children,” the release began.

“The Department’s investigations include healthcare fraud, false statements, and more.”

Attorney General Pam Bondi commented, “Medical professionals and organizations that mutilated children in the service of a warped ideology will be held accountable by this Department of Justice.”

Who exactly these 20 doctors are remains unknown, but they’ll have plenty to explain.

NBC News reported, the announcement came the same day that the Federal Trade Commission hosted a workshop on the “dangers of gender-affirming care,” featuring speakers like doctors, psychologists, and victims who had been harmed by those procedures.

Destransitioner Claire Abernathy was featured. She had a double mastectomy when she was 15 years old only to decide to detransition at 18. “My doctors didn’t tell me that hormones would cause permanent side effects,” she explained.

Keep reading

Cancer Patients Recover By Taking Repurposed Anti-Parasitic Drugs

Joe Tippens never planned to discover a potential remedy that he credits with saving his life and thrust him into the spotlight among notable cancer survivors. The 67-year-old businessman told The Epoch Times he just wanted to beat a type of cancer with an extremely low survival rate.

In August 2016, Tippens was diagnosed with small cell lung cancer with a fist-sized tumor. After undergoing chemotherapy and radiation five times a week in Houston, the large tumor in his left lung was eliminated. However, Tippens said the treatments came closer to killing him than curing him.

When he returned home to Oklahoma after the New Year, he received devastating news. His oncologist told him he had zero chance of surviving for more than a few months.

In January of 2017, my PET scan lit up like a Christmas tree and I had wide metastasis everywhere, including in my neck, bones, pancreas, and liver,” Tippens said.

Finding a Lifeline

Facing a prognosis of three months to live, Tippens heard an intriguing story from a veterinarian he knew: A scientist with terminal cancer reportedly cured her lab mice and then herself using fenbendazole, an antiparasitic drug.

The story was the beginning of what eventually became the “Joe Tippens Protocol.”

Fenbendazole, used for 30 years to treat intestinal parasites in animals, has not received U.S. Food and Drug Administration (FDA) approval for human use, meaning doctors cannot prescribe it for people. However, with a terminal diagnosis and nothing to lose, Tippens decided to try it alongside his conventional treatments.

Tippens found that Panacur, a trade name for fenbendazole, was sold over the counter at outlets that carry veterinary medications.

Starting in the third week of January 2017, Tippens began taking the canine medication, Panacur, 1 gram per day for three consecutive days per week. After four days without the medication, which contains about 222 milligrams of fenbendazole per gram, he would repeat his three-day routine. Three months later, Tippens was cancer-free.

His protocol also included Theracurmin, a form of the active compound in turmeric, and CBD, an extract of cannabis which does not cause intoxication.

Keep reading